##gff-version 3
##sequence-region P21549 1 392
P21549	UniProtKB	Chain	1	392	.	.	.	ID=PRO_0000150237;Note=Serine--pyruvate aminotransferase	
P21549	UniProtKB	Binding site	360	360	.	.	.	Note=Substrate	
P21549	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
P21549	UniProtKB	Modified residue	209	209	.	.	.	Note=N6-(pyridoxal phosphate)lysine	
P21549	UniProtKB	Modified residue	225	225	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35423	
P21549	UniProtKB	Modified residue	225	225	.	.	.	Note=N6-succinyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35423	
P21549	UniProtKB	Modified residue	234	234	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35423	
P21549	UniProtKB	Modified residue	312	312	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35423	
P21549	UniProtKB	Natural variant	9	9	.	.	.	ID=VAR_060547;Note=Polymorphism%3B no loss of alanine--glyoxylate aminotransferase activity. T->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15849466,ECO:0000269|PubMed:15961946,ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs115014558,PMID:15849466,PMID:15961946,PMID:17495019	
P21549	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_000587;Note=Common polymorphism%3B reduction of specific alanine--glyoxylate aminotransferase activity in vitro%3B causes mitochondrial mistargeting when associated with R-170. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10960483,ECO:0000269|PubMed:1703535;Dbxref=dbSNP:rs34116584,PMID:10960483,PMID:1703535	
P21549	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_048236;Note=N->S;Dbxref=dbSNP:rs34885252	
P21549	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_074582;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs180177157,PMID:17495019	
P21549	UniProtKB	Natural variant	41	41	.	.	.	ID=VAR_074583;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs180177168,PMID:17495019	
P21549	UniProtKB	Natural variant	41	41	.	.	.	ID=VAR_000588;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of protein stability%3B loss of alanine--glyoxylate aminotransferase activity%3B loss of dimerization%3B partial mitochondrial mistargeting%3B intraperoxisomal protein aggregation seen. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10541294,ECO:0000269|PubMed:10960483,ECO:0000269|PubMed:15961946,ECO:0000269|PubMed:16971151,ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:23229545,ECO:0000269|PubMed:8101040;Dbxref=dbSNP:rs121908523,PMID:10541294,PMID:10960483,PMID:15961946,PMID:16971151,PMID:17495019,PMID:23229545,PMID:8101040	
P21549	UniProtKB	Natural variant	41	41	.	.	.	ID=VAR_010969;Note=In HP1%3B reduced alanine--glyoxylate aminotransferase activity%3B no loss of dimerization%3B no effect on protein stability. G->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10394939,ECO:0000269|PubMed:10453743,ECO:0000269|PubMed:16971151;Dbxref=dbSNP:rs180177168,PMID:10394939,PMID:10453743,PMID:16971151	
P21549	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_074584;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in protein misfolding%3B decreased alanine--glyoxylate aminotransferase activity%3B reduced expression levels%3B reduced pyridoxal phosphate binding%3B reduced dimerization%3B reduced thermostability%3B increased propensity to aggregation%3B increased susceptibility to proteolytic degradation within the N-terminal region%3B mitochondrial mistargeting%3B exposure to pyridoxine can rescue the functionality by partially preventing aggregation and degradation and by redirecting all the protein to the peroxisome. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26149463;Dbxref=dbSNP:rs180177173,PMID:26149463	
P21549	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_008878;Note=In HP1%3B abolishes alanine--glyoxylate aminotransferase activity by interfering with pyridoxal phosphate binding. G->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10960483,ECO:0000269|PubMed:1349575,ECO:0000269|PubMed:16971151;Dbxref=dbSNP:rs121908522,PMID:10960483,PMID:1349575,PMID:16971151	
P21549	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_060548;Note=In HP1. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15253729;Dbxref=dbSNP:rs180177185,PMID:15253729	
P21549	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_010970;Note=In HP1. E->EE;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10394939,ECO:0000269|PubMed:10453743;Dbxref=PMID:10394939,PMID:10453743	
P21549	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_060549;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity%3B loss of dimerization%3B decreased protein stability. W->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15961946,ECO:0000269|PubMed:16971151,ECO:0000269|PubMed:9604803;Dbxref=dbSNP:rs180177197,PMID:15961946,PMID:16971151,PMID:9604803	
P21549	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_060550;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B loss of dimerization%3B decreased protein stability%3B causes protein aggregation. A->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12559847,ECO:0000269|PubMed:16971151;Dbxref=dbSNP:rs796052061,PMID:12559847,PMID:16971151	
P21549	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_010971;Note=In HP1. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10394939,ECO:0000269|PubMed:10453743;Dbxref=dbSNP:rs180177207,PMID:10394939,PMID:10453743	
P21549	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_060551;Note=In HP1. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15849466;Dbxref=PMID:15849466	
P21549	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_074585;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs180177222,PMID:17495019	
P21549	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_000589;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in protein destabilization%3B decreased alanine--glyoxylate aminotransferase activity%3B no loss of dimerization%3B mitochondrial mistargeting. F->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10862087,ECO:0000269|PubMed:10960483,ECO:0000269|PubMed:15253729,ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:23229545,ECO:0000269|PubMed:8101040;Dbxref=dbSNP:rs121908524,PMID:10862087,PMID:10960483,PMID:15253729,PMID:17495019,PMID:23229545,PMID:8101040	
P21549	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_060552;Note=In HP1. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15253729;Dbxref=dbSNP:rs180177223,PMID:15253729	
P21549	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_010972;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B loss of dimerization%3B decreased protein stability. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10394939,ECO:0000269|PubMed:10453743,ECO:0000269|PubMed:10541294,ECO:0000269|PubMed:15849466,ECO:0000269|PubMed:15961946,ECO:0000269|PubMed:16971151,ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs121908530,PMID:10394939,PMID:10453743,PMID:10541294,PMID:15849466,PMID:15961946,PMID:16971151,PMID:17495019	
P21549	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_060553;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15849466,ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs180177225,PMID:15849466,PMID:17495019	
P21549	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_074586;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity%3B reduced expression levels%3B decreased protein stability%3B protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate%3B reduced peroxisomal localization. G->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:24055001;Dbxref=dbSNP:rs180177227,PMID:17495019,PMID:24055001	
P21549	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_060554;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B reduced expression levels%3B decreased protein stability%3B protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate%3B loss of dimerization. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15963748,ECO:0000269|PubMed:16971151,ECO:0000269|PubMed:24055001;Dbxref=dbSNP:rs180177227,PMID:15963748,PMID:16971151,PMID:24055001	
P21549	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_074587;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity%3B reduced expression levels%3B decreased protein stability%3B protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate%3B reduced peroxisomal localization. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:24055001;Dbxref=dbSNP:rs180177227,PMID:17495019,PMID:24055001	
P21549	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_074588;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs180177230,PMID:17495019	
P21549	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_000590;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in mitochondrial mistargeting%3B slight decrease in alanine--glyoxylate aminotransferase activity%3B loss of dimerization%3B partial loss of protein stability but protein stability increases in the presence of pyridoxal phosphate%3B causes protein aggregation. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10862087,ECO:0000269|PubMed:10960483,ECO:0000269|PubMed:15253729,ECO:0000269|PubMed:16971151,ECO:0000269|PubMed:1703535,ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:23229545;Dbxref=dbSNP:rs121908529,PMID:10862087,PMID:10960483,PMID:15253729,PMID:16971151,PMID:1703535,PMID:17495019,PMID:23229545	
P21549	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_060555;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B loss of dimerization%3B decreased protein stability%3B causes protein aggregation. C->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16971151,ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:9604803;Dbxref=dbSNP:rs180177231,PMID:16971151,PMID:17495019,PMID:9604803	
P21549	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_010973;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B no loss of dimerization%3B no effect on protein stability. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10862087,ECO:0000269|PubMed:16971151;Dbxref=dbSNP:rs180177236,PMID:10862087,PMID:16971151	
P21549	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_000591;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B loss of dimerization but improved dimerization in the presence of pyridoxal phosphate%3B decreased protein stability. S->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1301173,ECO:0000269|PubMed:16971151;Dbxref=dbSNP:rs180177238,PMID:1301173,PMID:16971151	
P21549	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_060556;Note=In HP1. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10541294,ECO:0000269|PubMed:15849466,ECO:0000269|PubMed:15961946,ECO:0000269|PubMed:9604803;Dbxref=dbSNP:rs180177239,PMID:10541294,PMID:15849466,PMID:15961946,PMID:9604803	
P21549	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_060557;Note=In HP1. M->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15961946;Dbxref=dbSNP:rs180177244,PMID:15961946	
P21549	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_060558;Note=In HP1. D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15849466;Dbxref=dbSNP:rs180177246,PMID:15849466	
P21549	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_074589;Note=In HP1%3B unknown pathological significance. I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24934730;Dbxref=dbSNP:rs536352238,PMID:24934730	
P21549	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_000592;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B decreased protein stability. S->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16971151,ECO:0000269|PubMed:2039493;Dbxref=dbSNP:rs121908520,PMID:16971151,PMID:2039493	
P21549	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_060559;Note=In HP1%3B loss of alanine--glyoxylate aminotransferase activity%3B loss of dimerization%3B no effect on protein stability. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15963748,ECO:0000269|PubMed:16971151;Dbxref=dbSNP:rs180177253,PMID:15963748,PMID:16971151	
P21549	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_008879;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10862087,ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:9192270;Dbxref=dbSNP:rs121908526,PMID:10862087,PMID:17495019,PMID:9192270	
P21549	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_008880;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:9192270;Dbxref=dbSNP:rs121908527,PMID:17495019,PMID:9192270	
P21549	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_060560;Note=In HP1. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15849466;Dbxref=dbSNP:rs121908527,PMID:15849466	
P21549	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_060561;Note=In HP1. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15961946;Dbxref=dbSNP:rs180177258,PMID:15961946	
P21549	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_008881;Note=In HP1%3B prevalent mutation in the Canary islands%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in protein misfolding%3B decreased alanine--glyoxylate aminotransferase activity%3B no loss of dimerization%3B partial mitochondrial mistargeting. I->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10541294,ECO:0000269|PubMed:10862087,ECO:0000269|PubMed:10960483,ECO:0000269|PubMed:12777626,ECO:0000269|PubMed:15849466,ECO:0000269|PubMed:15961946,ECO:0000269|PubMed:17495019,ECO:0000269|PubMed:23229545,ECO:0000269|PubMed:9192270;Dbxref=dbSNP:rs121908525,PMID:10541294,PMID:10862087,PMID:10960483,PMID:12777626,PMID:15849466,PMID:15961946,PMID:17495019,PMID:23229545,PMID:9192270	
P21549	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_060562;Note=In HP1%3B when associated with L-11 and M-340 on the minor AGXT allele%3B results in loss of alanine--glyoxylate aminotransferase activity. C->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15849466,ECO:0000269|PubMed:17495019;Dbxref=dbSNP:rs180177264,PMID:15849466,PMID:17495019	
P21549	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_060563;Note=In HP1. I->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15961946;Dbxref=dbSNP:rs180177277,PMID:15961946	
P21549	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_060564;Note=I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15963748;Dbxref=dbSNP:rs140992177,PMID:15963748	
P21549	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_060565;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15963748;Dbxref=dbSNP:rs73106685,PMID:15963748	
P21549	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_060566;Note=In HP1. S->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15961946;Dbxref=dbSNP:rs180177289,PMID:15961946	
P21549	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_060567;Note=In HP1. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10541294,ECO:0000269|PubMed:15961946;Dbxref=dbSNP:rs180177290,PMID:10541294,PMID:15961946	
P21549	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_048237;Note=A->T;Dbxref=dbSNP:rs13408961	
P21549	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_060568;Note=In HP1. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9604803;Dbxref=PMID:9604803	
P21549	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_060569;Note=In HP1. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10541294,ECO:0000269|PubMed:15961946;Dbxref=dbSNP:rs180177293,PMID:10541294,PMID:15961946	
P21549	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_060570;Note=V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12559847;Dbxref=dbSNP:rs115057148,PMID:12559847	
P21549	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_060571;Note=In HP1. V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15253729;Dbxref=dbSNP:rs180177155,PMID:15253729	
P21549	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_000593;Note=Common polymorphism%3B associated with hyperoxaluria. I->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1703535;Dbxref=dbSNP:rs4426527,PMID:1703535	
P21549	UniProtKB	Natural variant	350	350	.	.	.	ID=VAR_060572;Note=In HP1. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9604803;Dbxref=dbSNP:rs180177156,PMID:9604803	
P21549	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Affects pyridoxal phosphate binding%3B loss of alanine--glyoxylate aminotransferase activity. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10960483,ECO:0000269|PubMed:16971151;Dbxref=PMID:10960483,PMID:16971151	
P21549	UniProtKB	Helix	13	15	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	27	29	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	35	41	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	51	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	73	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	82	93	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	99	106	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	107	118	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	122	127	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	136	146	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	149	156	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Turn	158	160	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	169	175	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	179	183	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Turn	185	190	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Turn	195	199	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	201	209	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	218	222	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	224	231	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	244	250	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	254	256	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	266	282	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	284	304	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	308	311	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	314	316	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	321	325	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	332	343	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	344	346	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4KYO	
P21549	UniProtKB	Helix	352	354	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Turn	355	357	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Beta strand	358	362	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	365	367	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
P21549	UniProtKB	Helix	370	386	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F9S	
